QuidelOrtho Corporation QDEL JPAC — Cost of sales, excluding amortization of intangibles

Other segment segments

Similar metrics at other companies

CSCOAPJC — Total cost of sales

$752M+12.7%

SNXAPJ — Cost of Revenue

$1.08B+15.8%

DGIIProduct — Cost of sales excluding amortization

$37.77M+18.9%

ABTDiagnostic Products — Cost of products sold, excluding amortization of intangible assets

$1.24B+7.8%

EYPTCost Of Sales Excluding Amortization Of Acquired Intangible Assets

$528K-34.4%

VTRSJANZ — Cost of Sales

$183.58M-8.0%

Questions, answered.

What is QuidelOrtho Corporation's JPAC — cost of sales, excluding amortization of intangibles?

QuidelOrtho Corporation (QDEL) reported JPAC — cost of sales, excluding amortization of intangibles of $41.5M in Q1 2026.

How has QuidelOrtho Corporation's JPAC — cost of sales, excluding amortization of intangibles changed year-over-year?

QuidelOrtho Corporation's JPAC — cost of sales, excluding amortization of intangibles increased by 9.5% year-over-year, from $37.9M to $41.5M.

What does JPAC — cost of sales, excluding amortization of intangibles mean?

Includes the direct costs associated with producing and delivering the diagnostic products sold by the JPAC segment, such as raw materials, labor, and manufacturing overhead. By excluding amortization, this metric provides a clearer view of the cash-based operational costs required to sustain the segment's revenue stream.